Ethical Data Feebris

On this week’s episode of Ethical Data, we’re joined by Jason Pontin. London born, California raised and educated in the United Kingdom, at Harrow School and Keble College, Oxford, Jason was the editor of Red Herring, the bible of the dot.com boom. From there he moved to MIT Technology Review, wrote a column for The New York Times and founded Solve, MIT’s open innovation platform.

In 2018 he left MIT to work directly with scientist entrepreneurs, first as a senior partner at Flagship Pioneering, a life sciences innovation firm that invents the technology of its portfolio companies. In 2021, he joined DCVC, which backs companies using deep tech to build a more abundant, resilient, and equitable future.

On this month's episode of Ethical Data, we’re joined by Leslie Kanthan, PhD, CEO at Turin Tech. TurinTech empowers businesses to build efficient and scalable AI by automating the whole data science lifecycle with multi-objective optimisation. 

Leslie and Elina talk all about sentience in AI, the next generation of data standards, the commercialisation of data in sensitive spaces like healthcare.

Our guest, Prashant Natarajan, focuses on the intersection of business outcomes, technology strategy, and digital transformation programs. He is currently the Vice President of Strategy and Products at H2O.ai. He is passionate about customer happiness, digital transformation successes and innovation at scale – with AI, advanced analytics, cloud, and data - for global clients in insurance, health sciences, banking, and manufacturing. 

Previously, Prashant was a Principal at Deloitte Consulting, global leader for data science and analytics at Unum Group, and portfolio director of cloud data platforms and analytics products at Oracle’s Health Sciences GBU.

Prashant is an author/co-author of five books, all of which are practical, industry-focused titles that demystify digital transformation, data, machine learning/AI, and healthcare informatics. He is an invited Co-faculty Instructor at Stanford University, a Distinguished Fellow at the Health Innovation Alliance, and Member of the Advisory Board at Pistoia Alliance AI Center of Excellence. 

Prashant has also been invited to contribute as an industry thought leader and expert advisor by members of the US Congress, the White House, and leading private sector organizations & governments in the Americas, Asia, Australia, and Europe. He has an undergraduate degree in chemical engineering and a graduate degree in technical communication and linguistics.

This week, Elina is joined by James Kugler, Chief Digital Officer of Merck. James received his Bachelor of Science in Biomedical Engineering from Washington University in St. Louis, USA. A passionate bioinformaticist / computer scientist, he has pursued several research activities at the MIT and Harvard Medical School to gain greater understanding of health sciences and technologies.

While completing a Ph.D. program, James received an attractive job offer as a corporate strategist and planner with Sigma Aldrich (part of the Merck Group since 2015) where he led the development of a scientific collaboration platform. In 2012, he became Head of Global New Product Development & Introduction and was responsible for the harmonization and streamlining of the product development process. In 2014, he became Director Global Digital Marketing and was responsible for the largest eCommerce platform in the life science industry. At the age of 28, he was appointed Chief Digital Officer of Merck. With his "disruptive" way of thinking, he leads a global unit in the digital age and is responsible for Merck's digital transformation worldwide.

James and Elina discuss:


Commercialisation of data in healthcare
Security of data and collaboration
Digital ethics
Regulation v contextualisation
Data as an enabling infrastructure
Traceability: The importance of infrastructure of the data
Data sets do not tell the whole story
Trustworthiness of data sources

To learn more about Elina's work, visit www.feebris.com

This week, Elina Naydenova is joined by Dr Shane Gordon, Director of Strategy, Research and Innovation at East Suffolk and North Essex NHS Foundation Trust and Dr Ashish Singh, an AI developer and Junior Doctor at East Sussex and North Essex NHS Foundation Trust, who's keen on developing digital aspects of healthcare delivery.

Elina, Shane and Ashish discuss the future of AI and technology in the NHS, and how regulation and practical needs and pressures impact innovation. Ashish suggests that maybe it's time we stopped calling it AI and Shane talks about why we must starting before we're ready, rather than waiting for perfect plans, to make real impact. 

To learn more about Elina's work, visit www.feebris.com

This week, Elina Naydenova is joined by Brhmie Balaram, Head of AI Research & Ethics for NHSX. She leads the Lab’s AI Ethics Initiative, which supports research and practical interventions that complement and strengthen existing efforts to validate, evaluate and regulate AI-driven technologies in health and care. Her focus is on addressing the inequalities that can emerge from the ways that AI-driven technologies are developed and deployed.

Elina and Indra discuss the AI trust problem, ethics and regulation, and creating a model for impact assessment with the Ada Lovelace Institute.  

To learn more about Elina's work, visit www.feebris.com